Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Feb 4, 2011

Premium

Origene Technologies this week released a full-length human MTOR protein, a protein kinase involved in regulation of cell growth, proliferation, motility, and survival, as well as protein synthesis and transcription.

Produced in mammalian cells, the protein is intended for use in high-throughput functional screening assays and drug target discovery and is the first commercially available full-length human MTOR protein, the company said.


Shimadzu and Perfinity Biosciences this week announced that they will be launching the Perfinity Workstation at Pittcon 2011.

The Workstation is a multi-column sample prep device that automates protein separation and mass-spec sample preparation, integrating affinity selection, buffer exchange, proteolysis, and desalting steps. It will allow researchers to start with serum and in ten minutes have peptides ready for LC/MS analysis, the companies said. Shimadzu will be previewing the platform via video next week at its booth at the Mass Spectrometry: Applications to the Clinical Lab conference in San Diego.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.